Caring Brands, Inc. has completed an underwritten public offering of 1,000,000 shares of its common stock at $4.00 per share, generating gross proceeds of approximately $4 million. The offering closed as the company uplisted to the Nasdaq Capital Market, with its shares commencing trading on November 13, 2025. The underwriter was granted a 45-day option to purchase up to an additional 150,000 shares.
The net proceeds from this capital raise are designated for general working capital, marketing and sales initiatives for proprietary products, and the repayment of certain debt. This financial injection is positioned to significantly advance the company's product development pipeline. Caring Brands operates as a wellness consumer products company with a portfolio of over-the-counter and cosmetic items. Its development pipeline targets treatments for hair loss, eczema, psoriasis, and vitiligo, and includes a protective suncare line designed to address jellyfish stings.
The company's operational methodology emphasizes establishing a clear mechanism of action for all products, determining efficacy through controlled clinical trials, and protecting innovations with issued and filed patents while ensuring commercial stability. Further details regarding the company's operations and product portfolio can be found at https://caringbrands.com/.
The announcement of these corporate developments was distributed by InvestorWire, a specialized communications platform within the Dynamic Brand Portfolio. InvestorWire provides wire-grade press release syndication and editorial distribution to over 5,000 outlets, alongside enhanced social media distribution. The full terms of use and disclaimers for the content are available on the InvestorWire website at https://www.InvestorWire.com/Disclaimer.
The successful public offering and Nasdaq listing collectively enhance Caring Brands' financial flexibility and public market visibility. This strategic move supports the company's goal of expanding the market reach of its clinically-validated wellness solutions. By addressing diverse consumer health needs with products grounded in established research and fortified by intellectual property protection, the company aims to solidify its position in the competitive wellness sector. The capital and increased profile are critical for scaling operations and bringing targeted therapeutic products from development to commercial availability.
